A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.

Condition:   Malignant Solid Tumor Interventions:   Drug: HDM201;   Drug: Ribociclib;   Drug: Cabozantinib Sponsor:   Centre Leon Berard Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials